Search

Clinical Articles / BY: R.C. Offer, MD, FRCPC, FACR October 2001
... efficacy for estrogen replacement therapy or etidronate. [ 2] Advising women about osteoporosis The primary-care ... a low T-score and no secondary causes for this ( Table 2 ), rarely suffers fragility fractures. She does, however, ... regimen. Quick-fix alendronate would be 10 mg daily for 2 years or, based on more recent data, 70 mg once a week [ ...
Letters / BY: Erik T. Paterson, MD June 2001
... ( The drug review process in BC: A critique. BCMJ 2001; 43(2):86-87 ) with respect to the Therapeutics Initiative (TI). ... lower cost and for a demonstrated value of more than 11/2 decades. Worse, TI has lent tacit support to the ...
Clinical Articles / BY: Benjamin C.L. Lai, MD, MSc April 2001
... in China to 657 in Argentina in door-to-door surveys,[ 2,3 ] and to vary from 100 to 250 in North America and ... in China in 1986 to 14.8 in Finland through 1968 to 1970.[ 2,4 ] The variation may partly reflect study design ... than in women in most studies, usually ranging from a 1.2:1 ratio up to a 1.5:1 ratio. Ethnic distribution The ...
Clinical Articles September 2001
... Populations were determined from Statistics Canada data.[ 2 ] We used the mean of the number of cardiologists listed by ... will be attracted to the province. A population growth of 2% per year in BC was used. The predicted number of ... study results are summarized here in  Table 1 ,  Table 2 , and  Figure 1 . Limitations  The model used to predict ...
Letters / BY: Eugene Leduc, MD May 2001
... them. Referring to a 1997 government-sponsored report,[ 2 ] Goble states that "only 30% of those who received a ...
Letters / BY: Peter J. Nunn, MB November 2001
... of amalgams releases about 30 micrograms a day. [ 2]  He also calculates that the transition of only 1 gram of ...
Clinical Articles / BY: H. Grant Stiver MD, FRCPC January/February 2000
... age groups and by 40% in elderly nursing home residents.[ 2 ] In spite of this, surveys indicate that even in patient ... (Tamiflu). Zanamivir was granted Health Canada approval on 2 November 1999 and oseltamivir on 24 December 1999. Both are ... Evidence for antiviral drug treatment of influenza Table 2  lists efficacy of amantadine and the antiviral agents ...
Clinical Articles / BY: Danuta M. Skowronski, MD, FRCPC June 2000
... patients become ill in the first 90 days after exposure.[ 2 ]  Rabies is primarily a disease of animals—humans are ... people require rabies post-exposure prophylaxis.[ 1,2 ]  The unwitting role played by bats Since 1925, 21 human ... bats from human dwellings by sealing openings as small as 2 cm and placing screens on windows. Professional bat control ...
Clinical Articles / BY: Steve Adilman, MD November 2000
... and is the home for about 4700 injection drug users.[ 1,2 ] The epicentre of the drug trade is located 3 blocks from ... of HIV for all patients that attended VNHS was 9.2%. The prevalence of HIV for males was 9%, for females it ... clinic patients, females 34%, and transgenders 2% ( Figure 1 ). The patients ranged in age from 16 to 64 ...
Clinical Articles / BY: Iain G.M. Cleator, MB, CHB, FRCSC, FRCSE, FRCS, FACS April 2000
... at least 6 years for this transformation to occur.[ 1,2 ]  Under current accepted standards of screening and ... compliant was 44%. Interestingly, the group screened every 2 years had a reduction in mortality of 6%. The rate of ... without rehydration in a screening program conducted every 2 years. Their colonoscopy rate was 4.3%. The predicted ...